/

Lycia Therapeutics

Develops therapeutics that target and degrade disease-causing proteins.

BiotechnologyPharmaceuticals lyciatx.com ↗

Company facts

Founded: 2019
Employees: 38
Headquarters: United States
Type: Private
Funding: Series C · $106.6M · 2024